Filing Flows

Filing Flows › Stoke Therapeutics (STOK) › Who owns the stock

Who owns Stoke Therapeutics (STOK) stock

179 funds reported Stoke Therapeutics (STOK) shares in their latest 13F filings, worth $2.7B in all. The largest holder is BlackRock ($192M). Last quarter 90 funds added to their stakes and 79 cut them.

Largest holders of STOK (13F)Largest holders of STOK (13F)BlackRock$192MRTW Investments, LP$184MFMR LLC$174MLynx1 Capital Management LP$132MRedmile Group, LLC$129MWellington Management Group LLP$115MMorgan Stanley$113MBaker Bros. Advisors LP$109MToronto Dominion Bank$104MVanguard Group$100M

Largest holders (13F)

FundSharesValueChangeQuarter
BlackRock5,877,357$192Mincrease2026-06-30
RTW Investments, LP5,623,525$184Munchanged2026-06-30
FMR LLC5,313,100$174Mdecrease2026-06-30
Lynx1 Capital Management LP4,038,404$132Mdecrease2026-06-30
Redmile Group, LLC3,945,920$129Mdecrease2026-06-30
Wellington Management Group LLP3,519,301$115Mincrease2026-06-30
Morgan Stanley3,452,795$113Mincrease2026-06-30
Baker Bros. Advisors LP3,336,697$109Munchanged2026-06-30
Toronto Dominion Bank3,173,258$104Munchanged2026-06-30
Vanguard Group3,149,239$100Mdecrease2025-12-31
State Street2,852,240$93.3Mincrease2026-06-30
Price T Rowe Associates2,661,739$87.1Mincrease2026-06-30
Vanguard Capital Management LLC2,586,937$84.6Mincrease2026-06-30
BVF2,547,557$83.4Munchanged2026-06-30
T. Rowe Price Investment Management2,415,139$79.0Mincrease2026-06-30

Stoke Therapeutics' latest quarter

Stoke Therapeutics, Q3 2026: revenue $11.3M (+6% year over year), operating margin -686.9%, net loss $73.6M, operating cash flow −$62.7M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most STOK stock?

By the latest 13F filings: BlackRock ($192M); RTW Investments, LP ($184M); FMR LLC ($174M); Lynx1 Capital Management LP ($132M); Redmile Group, LLC ($129M).

What is the short interest in STOK?

10,256,830 shares were sold short at the 2026-10-15 settlement, -10.85% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.